Last update 01 Nov 2024

URAT1 x SLC22A11 x XO

Basic Info

Related Targets
URAT1SLC22A11XO

Related

1
Drugs associated with URAT1 x SLC22A11 x XO
Allopurinol/Lesinurad
Target
SLC22A11 x URAT1 x XO
Mechanism
SLC22A11 inhibitors [+2]
Active Org.-
Originator Org.
Ironwood Pharmaceuticals, Inc.Ironwood Pharmaceuticals, Inc.
Active Indication-
Inactive Indication
Gout [+1]
Drug Highest PhaseWithdrawn
First Approval Ctry. / Loc.
US
First Approval Date18 Aug 2017
100 Clinical Results associated with URAT1 x SLC22A11 x XO
Login to view more data
100 Translational Medicine associated with URAT1 x SLC22A11 x XO
Login to view more data
0 Patents (Medical) associated with URAT1 x SLC22A11 x XO
Login to view more data

Analysis

Perform a panoramic analysis of this field.
login
or
view full example data
Perform a panoramic analysis of this field.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free